Erin Joseph

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

William C. Zamboni, Anne Gervais, Merrill J. Egorin et al. · Cancer Chemotherapy and Pharmacology · 2004 · 164 citations

Medicine, Oncology, Pharmacology +12

Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts

Julie L. Eiseman, Jing Lan, Theodore Lagattuta et al. · Cancer Chemotherapy and Pharmacology · 2004 · 152 citations

Medicine, Pharmacokinetics, Pharmacology +11

Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice

Jianxia Guo, Robert A. Parise, Erin Joseph et al. · Cancer Chemotherapy and Pharmacology · 2008 · 121 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +3

Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine

Julianne L. Holleran, Robert A. Parise, Erin Joseph et al. · Clinical Cancer Research · 2005 · 96 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

<i>N</i>-(2-Hydroxypropyl)methacrylamide Copolymers of a Glutathione (GSH)-Activated Glyoxalase I Inhibitor and DNA Alkylating Agent:  Synthesis, Reaction Kinetics with GSH, and in Vitro Antitumor Activities

Zhe-Bin Zheng, Guo‐Zhang Zhu, Heekyung Tak et al. · Bioconjugate Chemistry · 2005 · 88 citations

Medicine, Oncology, Pharmacology +15